TY - JOUR
T1 - Neoadjuvant chemotherapy for Non-Small-Cell lung cancer
T2 - Does it really impact on postoperative outcome after lung resection?
AU - Voltolini, L.
AU - Rapicetta, C.
AU - Ligabue, T.
AU - Scolletta, S.
AU - Ghiribelli, C.
AU - Gotti, G.
PY - 2011
Y1 - 2011
N2 - BACKGROUND Although some studies seem to indicate a positive prognostic value of induction chemotherapy in patients with locally advanced Non-Small-Cell Lung Cancer (NSCLC), its impact on postoperative mortality and morbidity is not well established. MATERIALS AND METHODS We reviewed the records of 83 consecutive patients who underwent thoracotomy after induction therapy between 1996 and 2007 (Group 1). Results were compared to those of a control group of 166 patients surgically treated in the same period without prior neoadjuvant therapy (Group 2). RESULTS The two groups were matched for age, sex, histology, comorbidity, respiratory function, and surgical procedure. There was no hospital mortality. Cumulative incidence of major complications was 32% in Group 1 and 37% in Group 2 (p=0.18). The incidence of each complication considered did not significantly differ between the two groups. A higher percentage of patients in Group 1 required blood transfusions (21.7% vs 4.2%, p
AB - BACKGROUND Although some studies seem to indicate a positive prognostic value of induction chemotherapy in patients with locally advanced Non-Small-Cell Lung Cancer (NSCLC), its impact on postoperative mortality and morbidity is not well established. MATERIALS AND METHODS We reviewed the records of 83 consecutive patients who underwent thoracotomy after induction therapy between 1996 and 2007 (Group 1). Results were compared to those of a control group of 166 patients surgically treated in the same period without prior neoadjuvant therapy (Group 2). RESULTS The two groups were matched for age, sex, histology, comorbidity, respiratory function, and surgical procedure. There was no hospital mortality. Cumulative incidence of major complications was 32% in Group 1 and 37% in Group 2 (p=0.18). The incidence of each complication considered did not significantly differ between the two groups. A higher percentage of patients in Group 1 required blood transfusions (21.7% vs 4.2%, p
KW - Chemotherapy
KW - Complications
KW - Lung cancer
KW - Mortality
UR - http://www.scopus.com/inward/record.url?scp=79958159196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79958159196&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:79958159196
SN - 1759-8958
VL - 3
SP - 57
EP - 63
JO - European journal of Clinical and Medical Oncology
JF - European journal of Clinical and Medical Oncology
IS - 2
ER -